Avantor (AVTR) return on equity (ROE)

Return on equity · fiscal 2025
-9.5%

Avantor (AVTR) earned a return on equity of -9.5% in fiscal 2025 (the year ended December 31, 2025). That is 21.5 percentage points lower than the 11.9% of fiscal 2024. Figures as of 17 Nov 2026, 21:22 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-9.5%
Change on fiscal 2024
−21.5 pts
Highest on record
14.1%fiscal 2022
Lowest on record
-9.5%fiscal 2025
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Avantor return on equity (ROE), in more detail

Across the 7 fiscal years on record (2019–2025), the highest was 14.1% in fiscal 2022 and the lowest -9.5% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 6 earlier fiscal years on record, whose median is 9.0%.

History · 7 fiscal years

Return on equity by fiscal year

Avantor return on equity (ROE), year by year

Avantor (AVTR) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-9.5% 21.5 pts down
202411.9% 5.8 pts up
20236.1% 8.0 pts down
202214.1% 0.5 pts up
202113.6% 9.3 pts up
20204.4% 2.8 pts up
20191.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Avantor and comparable companies
CompanyReturn on equityFiscal year
BioMarin Pharmaceutical BMRN5.7%2025
Avantor AVTR-9.5%2025
Ensign Group ENSG15.4%2025
Vaxcyte PCVX-28.5%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AVTR

Avantor, figure by figure

Avantor (AVTR) overview: price, valuation and scorecardAll health care companies by market value

Avantor return on equity (ROE): questions and answers

What is Avantor's return on equity?

Avantor (AVTR) earned a return on equity of -9.5% in fiscal 2025 (the year ended December 31, 2025). That is 21.5 percentage points lower than the 11.9% of fiscal 2024.

Is Avantor's return on equity high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 6 earlier fiscal years on record, whose median is 9.0%.

What are the highest and lowest return on equity figures on record for Avantor?

Across the 7 fiscal years on record (2019–2025), the highest was 14.1% in fiscal 2022 and the lowest -9.5% in fiscal 2025.

How is Avantor's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Avantor (AVTR) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/AVTR/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.